ONCO
Onconetix, Inc.
Nasdaq Pharmaceutical Preparations
Emerging growth company

Key Financials

Revenue
$815371
↓ 67.7%
Gross Profit
$632913
↓ 40.0%
Operating Income
$-17856856
↑ 68.4%
EPS (Diluted)
$-16.56
↑ 22.8%
Total Assets
$24.9M
↓ 11.5%
Total Liabilities
$9.2M
↓ 50.7%
Shareholders' Equity
$8.5M
↑ 252.5%
Net Income
$-14032342
↑ 76.1%

Recent SEC Filings

Form Type Filed Date Link
425 6/24/2026 View on SEC
424B3 6/17/2026 View on SEC
EFFECT 6/16/2026 View on SEC
S-1 6/9/2026 View on SEC
8-K 5/19/2026 View on SEC
8-K 5/14/2026 View on SEC
10-Q 5/13/2026 View on SEC
424B3 5/12/2026 View on SEC
EFFECT 5/11/2026 View on SEC
EFFECT 5/7/2026 View on SEC

Company Information

Field Value
Ticker ONCO
Company Name Onconetix, Inc.
CIK 1782107
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 513-620-4101